Concepedia

Prognostic significance of circulating CD19+ B lymphocytes in EBV-associated nasopharyngeal carcinoma

Tao Xu, Zheli Huang, Bojin Su, Sumei Wang, Donghui Wang, Chunhua Wang, Weihong Wei, Jun Jiang, Guoyi Zhang, Huiling Yang,

Medical Oncology · 2014 · 19 citations · 25 references

Concepts

MedicineInfectious DiseasesOncologyCancer ImmunologyMolecular OncologyTumor ImmunologyCirculating Tumor CellsImmuno-oncology BiomarkersNasopharyngeal CancerOncogenic VirusesTumor AntigensTumor-infiltrating LymphocytesCancer AntigensEpstein-barr Virus - Associated Lymphoid NeoplasmsEpstein-barr Virus - Associated MalignanciesEpstein-barr Virus PersistenceEpstein-barr Virus-associated CarcinogenesisLymphocyte SubtypesViral Tumor Antigens

References

25

Global cancer statistics

Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

Epstein–Barr Virus Infection

Jeffrey I. Cohen · New England Journal of Medicine · 2000 · 1.6K citations

Veterinary Medicine, Infectious Diseases, Microbiology +15

Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma

Jin‐Ching Lin, Wenyi Wang, Kuang Yu Chen et al. · New England Journal of Medicine · 2004 · 922 citations · Full text

Medicine, Molecular Biology, Oncology +15

CD4 + T Cell–Mediated Tumor Rejection Involves Inhibition of Angiogenesis that Is Dependent on IFNγ Receptor Expression by Nonhematopoietic Cells

Zhihai Qin, Thomas Blankenstein · Immunity · 2000 · 499 citations · Full text

Medicine, Immunology, Oncology +14

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes

Karin Straathof, Catherine M. Bollard, Uday Popat et al. · Blood · 2004 · 351 citations

Life Sciences, Immunology, Oncology +12